News & Articles

These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season

Additional real-world data demonstrate meaningful outcomes for people living with diabetes who use Abbott's glucose sensing technology

The RECOVERY trial has shown that the cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19

It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

LifeShare Blood Center deploys Biolog-id’s cutting-edge technology providing digital visibility to convalescent plasma containing antibodies from recovered COVID-19 patients

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications

Our expert webinar series aims to help you get the most from your drug discovery research

The RECOVERY trial has shown that hydroxychloroquine is not an effective treatment in patients hospitalized with COVID-19

This aims to make use of its collective and accumulated knowledge of graphene to fight the current pandemic

Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity

Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

A rare lung disease drug is being trialed to help fight COVID-19

The study is expected to begin enrolling in June with a target of approximately 450 patients globally

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

The RNAdvance Viral XP is a RNA extraction kit validated for use in infectious disease and real-time PCR virus research

Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers' specific analytical requirements

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus